HER2 overexpression has been investigated as a potential biomarker and therapeutic target in biliary tract cancer (BTC), but a prognostic role of such alteration has not been demonstrated yet.
HER2 overexpression as a poor prognostic determinant in resected biliary tract cancer
Vivaldi, Caterina;Ugolini, Clara;Niccoli, Cristina;Musettini, Gianna;Pecora, Irene;Cacciato Insilla, Andrea;Salani, Francesca;Pasquini, Giulia;Catanese, Silvia;Masi, Gianluca;Campani, Daniela;Falcone, Alfredo;Vasile, Enrico
2020-01-01
Abstract
HER2 overexpression has been investigated as a potential biomarker and therapeutic target in biliary tract cancer (BTC), but a prognostic role of such alteration has not been demonstrated yet.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
